Resverlogix Corp.

TSX Exchange | Feb 17, 2020, 1:09 AM EST | Real-time price

RVX $ 1.38 RT
0.08 (6.1538%)
Day Low: 1.28
Day High: 1.43
Detailed Quote
Open: 1.34
High: 1.43
Beta: 0.08104
Listed Shares Out.1: 210,709,788
Total Shares (All Classes)2: 209,457,782
Prev. Close: 1.30
Low: 1.28
VWAP: 1.3493
Market Cap1: 290,779,507
Market Cap (All Classes)2*: 289,051,739
Dividend: N/A
Div. Frequency: N/A
P/E Ratio: N/A
EPS: -2.40
Yield: N/A
Ex-Div Date: N/A
P/B Ratio: -2.654
Exchange: TSX

(1) Number based only on listed classes of shares.

(2) Number sourced from third party data provider. For the most up to date information, please refer to the company's financial documents.

*Market Capitalization is based on Total Shares Outstanding for all share classes for the company. Convertible bonds and employee stock options that would otherwise be included in the Diluted Shares amount included in a company's filings/financials are not included.


Resverlogix Corp clinical-stage biotechnology company. The company is developing an advanced epigenetic drug called apabetalone for the treatment of patients with cardiovascular disease, diabetes mellitus, chronic kidney disease, peripheral artery disease, orphan diseases, and neurodegenerative diseases. More

Last 25 Trades
Copyright © QuoteMedia. Data delayed 15 minutes unless otherwise indicated. View delay times for all exchanges. Market Data powered by QuoteMedia, Fundamentals by Morningstar. See the QuoteMedia Terms of Use.